- Home
- ONCY vs FONR Comparison
ONCY vs FONR Comparison
Compare ONCY & FONR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ONCY | FONR |
|---|---|---|
| Founded | 1998 | 1978 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 106.1M | 88.3M |
| IPO Year | 1999 | 1987 |
Fundamental Metrics
Financial Performance| Metric | ONCY | FONR |
|---|---|---|
| Price | $1.03 | $15.05 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 683.5K | 33.3K |
| Earning Date | 11-12-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.08 |
| Revenue | N/A | ★ $105,434,318.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $13.89 |
| Revenue Growth | N/A | ★ 3.36 |
| 52 Week Low | $0.33 | $12.00 |
| 52 Week High | $1.51 | $17.62 |
Technical Indicators
Market Signals| Indicator | ONCY | FONR |
|---|---|---|
| Relative Strength Index (RSI) | 50.54 | 58.50 |
| Support Level | $0.92 | $14.35 |
| Resistance Level | $1.06 | $14.91 |
| Average True Range (ATR) | 0.06 | 0.32 |
| MACD | 0.01 | 0.09 |
| Stochastic Oscillator | 77.46 | 89.92 |
Price Performance
Historical ComparisonAbout ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.
About FONR Fonar Corporation
Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue.